Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial

Detalles Bibliográficos
Autores principales: Ram, Zvi, Kim, Chae-Yong, Hottinger, Andreas F., Idbaih, Ahmed, Nicholas, Garth, Zhu, Jay-Jiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040518/
https://www.ncbi.nlm.nih.gov/pubmed/35494031
http://dx.doi.org/10.3389/fonc.2022.902929
_version_ 1784694354055528448
author Ram, Zvi
Kim, Chae-Yong
Hottinger, Andreas F.
Idbaih, Ahmed
Nicholas, Garth
Zhu, Jay-Jiguang
author_facet Ram, Zvi
Kim, Chae-Yong
Hottinger, Andreas F.
Idbaih, Ahmed
Nicholas, Garth
Zhu, Jay-Jiguang
author_sort Ram, Zvi
collection PubMed
description
format Online
Article
Text
id pubmed-9040518
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90405182022-04-27 Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial Ram, Zvi Kim, Chae-Yong Hottinger, Andreas F. Idbaih, Ahmed Nicholas, Garth Zhu, Jay-Jiguang Front Oncol Oncology Frontiers Media S.A. 2022-04-12 /pmc/articles/PMC9040518/ /pubmed/35494031 http://dx.doi.org/10.3389/fonc.2022.902929 Text en Copyright © 2022 Ram, Kim, Hottinger, Idbaih, Nicholas and Zhu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ram, Zvi
Kim, Chae-Yong
Hottinger, Andreas F.
Idbaih, Ahmed
Nicholas, Garth
Zhu, Jay-Jiguang
Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
title Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
title_full Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
title_fullStr Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
title_full_unstemmed Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
title_short Corrigendum: Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients With Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
title_sort corrigendum: efficacy and safety of tumor treating fields (ttfields) in elderly patients with newly diagnosed glioblastoma: subgroup analysis of the phase 3 ef-14 clinical trial
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040518/
https://www.ncbi.nlm.nih.gov/pubmed/35494031
http://dx.doi.org/10.3389/fonc.2022.902929
work_keys_str_mv AT ramzvi corrigendumefficacyandsafetyoftumortreatingfieldsttfieldsinelderlypatientswithnewlydiagnosedglioblastomasubgroupanalysisofthephase3ef14clinicaltrial
AT kimchaeyong corrigendumefficacyandsafetyoftumortreatingfieldsttfieldsinelderlypatientswithnewlydiagnosedglioblastomasubgroupanalysisofthephase3ef14clinicaltrial
AT hottingerandreasf corrigendumefficacyandsafetyoftumortreatingfieldsttfieldsinelderlypatientswithnewlydiagnosedglioblastomasubgroupanalysisofthephase3ef14clinicaltrial
AT idbaihahmed corrigendumefficacyandsafetyoftumortreatingfieldsttfieldsinelderlypatientswithnewlydiagnosedglioblastomasubgroupanalysisofthephase3ef14clinicaltrial
AT nicholasgarth corrigendumefficacyandsafetyoftumortreatingfieldsttfieldsinelderlypatientswithnewlydiagnosedglioblastomasubgroupanalysisofthephase3ef14clinicaltrial
AT zhujayjiguang corrigendumefficacyandsafetyoftumortreatingfieldsttfieldsinelderlypatientswithnewlydiagnosedglioblastomasubgroupanalysisofthephase3ef14clinicaltrial

Ejemplares similares